Galecto Inc
NASDAQ:GLTO
Galecto Inc
Other Current Liabilities
Galecto Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Other Current Liabilities
$1.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Other Current Liabilities
kr2.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
46%
|
CAGR 10-Years
12%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Other Current Liabilities
kr10.1m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-5%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Other Current Liabilities
€265.1m
|
CAGR 3-Years
181%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Other Current Liabilities
kr2.1B
|
CAGR 3-Years
172%
|
CAGR 5-Years
153%
|
CAGR 10-Years
27%
|
Bioporto A/S
CSE:BIOPOR
|
Other Current Liabilities
kr79k
|
CAGR 3-Years
-85%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-36%
|
See Also
What is Galecto Inc's Other Current Liabilities?
Other Current Liabilities
1.2m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Other Current Liabilities amounts to 1.2m USD.
What is Galecto Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-16%
Over the last year, the Other Current Liabilities growth was -82%. The average annual Other Current Liabilities growth rates for Galecto Inc have been -2% over the past three years , -16% over the past five years .